Accolade CEO Rajeev Singh sells shares worth over $1,500

In a recent transaction, Rajeev Singh, the Chief Executive Officer of Accolade, Inc. (NASDAQ:ACCD), sold shares of the company's common stock. The sale, which took place on September 17, 2024, involved 366 shares at a price of $4.318 per share, totaling over $1,580. This transaction was carried out to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).


The disposal of shares by Singh was part of a mandatory sell-to-cover transaction, which is a common practice for executives to satisfy tax obligations that arise from the vesting of equity awards. It's important to note that such sales are often required and do not necessarily indicate a change in the executive's view of the company's prospects.


Accolade, Inc., with its headquarters in Plymouth Meeting, PA, operates in the business services sector, providing a range of services to its clientele. The company has been publicly traded and continues to be a subject of interest for investors tracking insider transactions.


Singh's recent transaction follows the acquisition of 933 shares on September 16, 2024, which did not involve any monetary transaction as it was related to the conversion of RSUs into common stock. These units converted on a one-to-one basis and were part of a pre-determined vesting schedule that was established back in June 2021.


It is also noted that Singh has indirect ownership of shares through Avanti Holdings, LLC, where he is a partner with voting and investment power. The shares owned by Avanti Holdings, LLC amount to a total of 651,619 shares of Accolade's common stock.


Investors and market watchers often pay close attention to insider transactions as they provide insights into executives' perspectives on the company's value and future performance. However, transactions like Singh's are often planned in advance and can be related to personal financial management rather than direct reflections of corporate outlook.


For those interested in Accolade's stock movements and insider activities, the company trades under the ticker symbol ACCD on the NASDAQ exchange.



In other recent news, Accolade Inc. reported an 18% year-over-year revenue growth for the first quarter of fiscal year 2025, totaling $110.5 million. However, the company revised its full-year revenue outlook for 2025 to between $460 million and $475 million, indicating a growth of 11% to 15%. Financial services firm Stifel, along with analyst firms Canaccord Genuity, Needham, Truist Securities, and DA Davidson have all adjusted their price targets for Accolade, while maintaining positive ratings, following the company's revised earnings guidance.


Accolade's decision to lower usage-based revenue projections and marketing investments to prioritize profitability has influenced its revised revenue forecast. Despite this, the company's EBITDA outlook for FY25 remains positive, ranging from $15 million to $20 million. Accolade's long-term revenue goal of $1 billion has been postponed by approximately one year.


The recent developments have led to additional questions regarding the sustainability and growth of the company. The next significant indicator for Accolade's performance will be the third-quarter results. Despite the recent adjustments, Stifel, Needham, and Truist Securities maintain a 'Buy' rating, while DA Davidson holds a 'Neutral' rating. These ratings come after the analysts revised their price targets for Accolade, with Stifel adjusting to $8, Needham to $8, Truist to $9, and DA Davidson to $5.
InvestingPro Insights


Accolade, Inc. (NASDAQ:ACCD) has been navigating a challenging market environment, as reflected in the company's stock price movements. An InvestingPro Tip highlights the stock's volatility, which could be a consideration for investors looking at the recent insider transactions. Additionally, analysts have revised their earnings downwards for the upcoming period, suggesting that the market may have concerns about the company's short-term performance.


On the financial front, Accolade's market capitalization stands at $343.24 million, indicating its size within the business services sector. Despite a negative P/E ratio of -3.72, which suggests the company is not currently profitable, the company's revenue growth has been positive, with a 16.37% increase over the last twelve months as of Q1 2023. This growth is complemented by a solid gross profit margin of 47.49% for the same period. However, it's worth noting that the company's operating income margin was -24.02%, reflecting the costs and expenses relative to its revenue.


Investors considering Accolade's stock should be aware that the company does not pay dividends, which can be a determining factor for those seeking income-generating investments. For more in-depth analysis and additional InvestingPro Tips, including the company's shareholder yield and liquidity position, interested parties can visit https://www.investing.com/pro/ACCD, where 9 more tips are available to provide a comprehensive understanding of Accolade's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com

Последние публикации
SAIC Volkswagen says adjusting plant base "necessary"
21.09.2024 - 13:00
Selling season, election ahead, but keep an eye on ’25, says Wells Fargo
21.09.2024 - 13:00
Investors should de-risk ahead of US elections, BCA says
21.09.2024 - 13:00
How to play the AI Enterprise Software revolution
21.09.2024 - 12:00
Qualcomm approached Intel about a takeover in recent days, source says
21.09.2024 - 08:00
Eliem therapeutics executive sells over $9,000 in company stock
21.09.2024 - 06:00
Nvidia's principal accounting officer sells shares worth over $520,000
21.09.2024 - 05:00
Mara Holdings CFO sells over $262k in company stock
21.09.2024 - 05:00
Mara Holdings CEO sells shares worth over $430k
21.09.2024 - 05:00
Nvidia CFO Colette Kress sells shares worth over $7.7 million
21.09.2024 - 05:00
X names Brazil legal representative as it fights ban in the country
21.09.2024 - 05:00
Viking therapeutics director sells shares worth over $715,000
21.09.2024 - 05:00
Viking therapeutics CEO sells over $15m in company stock
21.09.2024 - 05:00
Natera co-founder sells over $2.8 million in company stock
21.09.2024 - 05:00
Palantir Technologies sells Rubicon Technologies shares worth over $9k
21.09.2024 - 04:00

© Analytic DC. All Rights Reserved.

new
Анализ трейдера Анализ трейдера за 20.09.24
Добро пожаловать в чат поддержки!
*
*

Ваш запрос успешно отправлен!
Скоро с вами свяжутся.